| Drug Type Small molecule drug | 
| Synonyms SHIGMABITAN, VITAMEDIN, シグマビタン + [1] | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Japan (01 Sep 2009),  | 
| Regulation- | 
| Molecular FormulaC19H23N4O6PS | 
| InChIKeyBTNNPSLJPBRMLZ-UHFFFAOYSA-N | 
| CAS Registry22457-89-2 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Avitaminosis | Japan  | 01 Sep 2009 | |
| Avitaminosis | Japan  | 01 Sep 2009 | 





